Source:http://linkedlifedata.com/resource/pubmed/id/11798132
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-1-18
|
pubmed:abstractText |
Interleukin 5 (IL-5) is a cytokine primarily involved in the pathogenesis of atopic diseases. It specifically controls the production, activation and localization of eosinophils, the major cause of tissue damage in atopic diseases. IL-5 belongs to a gene family shared by IL-3, IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF) and is predominantly regulated at the transcriptional level. A variety of stimuli and modulators have been identified as regulating production of IL-5 both in vivo and in vitro, indicating a highly complex series of control mechanisms. However, a better understanding of the biology of IL-5 and the regulation of its expression is crucial for the development of new therapeutic agents for allergic disease. This review covers the major molecular aspects of IL-5 research.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0004-069X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-51
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11798132-Animals,
pubmed-meshheading:11798132-Eosinophils,
pubmed-meshheading:11798132-Gene Expression Regulation,
pubmed-meshheading:11798132-Humans,
pubmed-meshheading:11798132-Hypersensitivity,
pubmed-meshheading:11798132-Interleukin-5,
pubmed-meshheading:11798132-Mice,
pubmed-meshheading:11798132-Promoter Regions, Genetic,
pubmed-meshheading:11798132-Transcription, Genetic
|
pubmed:year |
2001
|
pubmed:articleTitle |
Regulation of IL-5 expression.
|
pubmed:affiliation |
Curtin University of Technology, Perth, Western Australia. slava@cyllene.uwa.edu.au
|
pubmed:publicationType |
Journal Article,
In Vitro,
Review
|